title: Letter by turc et Al regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".
authors.affiliation: Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes & INSERM UMR 894, Paris, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Turc
authors.affiliation: Department of Radiology, Hôpital Sainte-Anne, Paris, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Tisserand
authors.affiliation: Department of Neurology, Hôpital Sainte-Anne, Paris, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Seners
authors.affiliation: Department of Radiology, Hôpital Sainte-Anne, Université Paris Descartes & INSERM UMR 894, Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Oppenheim
authors.affiliation: Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes & INSERM UMR 894, Paris, France.
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Baron
mesh_terms: D002543:Cerebral Hemorrhage / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D020521:Stroke / Q000175:diagnosis* / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods* / Q000592:standards*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D010959:Tissue Plasminogen Activator